September 9, 2020
Greater Bay Area Planning | Dr. H. Fai Poon, CEO of QuaCell Biotechnology, was invited to share the cooperation policy recommendations of the Association for Science and Technology
As an important gateway for national economic development and opening up, the Guangdong-Hong Kong-Macao Greater Bay Area plays an inestimable role in national construction. Creating a global highland for technological innovation and an important source of emerging industries is an important part of the Greater Bay Area plan. The Greater Bay Area is expected to become an international science and innovation center in the future. Thanks to its geographical advantages, the Greater Bay Area's planning is conducive to exploring the cross-border flow and regional integration of innovative elements such as talent, capital, information, and technology, and jointly building the Guangdong-Hong Kong-Macao Greater Bay Area big data center and a national innovation platform.
Therefore, in August 2020, the Hong Kong Association for Science and Technology, Director Xue, and Deputy Director Zhong of the Hong Kong Innovation and Technology Bureau conducted a discussion on why Zhongshan was chosen as the pilot for the start-up park. Dr.H. Fai Poon, CEO of QuaCell Biotechnology, was invited to participate in the sharing.
At the meeting, Dr. Poon briefly introduced the general situation of QuaCell. He analyzed the market, policies, and customer base. As an important node connecting the Guangdong-Hong Kong-Macao Greater Bay Area, Zhongshan has a talent subsidy policy. As a Hong Kong-mainland joint venture established for nearly three years, QuaCell Biotechnology has achieved today's achievements because of its policy support and its own development. Favorable policies can provide more and better development opportunities for late-stage start-ups. If there is a demand for new technologies and new products, Hong Kong's financial advantages can also be used to achieve listing and expansion opportunities in the international market.
As one of the Greater Bay Area companies, QuaCell Biotechnology will spare no effort to give full play to its policy advantages and its own advantages to achieve rapid development and form a certain scale.
In general, the policy is to give full play to the advantages of the Guangdong-Hong Kong-Macao Greater Bay Area so that high-quality start-ups in the Greater Bay Area and Hong Kong can combine different market advantages and policies to form a better entrepreneurial environment.
Drug Master Files are available for the QuaCell® CHO cell culture mediums, facilitating applications for antibody drugs
QuaCell Biotechnology launched its Innovation Research Center in Guangzhou